Author: Dr. David Lowemann

FTC Sues Drug ‘Gatekeepers’ Over High Insulin Prices

The U.S. Federal Trade Commission sued the country’s three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies. The case accuses… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder […]

Published on September 20, 2024

Adding nuance to link between brain structure and ideology

Using MRI scans of almost 1,000 Dutch people, researchers show that there is indeed a connection between brain structure and ideology. However, the connection is smaller than expected. Nevertheless, the researchers find it remarkable that differences in the brain are linked to something as abstract as ideology. Read Full Article (External Site) Dr. David LowemannDr. […]

Published on September 20, 2024

Response to Goddu et al.: new ways of characterizing and acquiring knowledge

In a recent opinion in TiCS [1], we asked: ‘What do large language models (LLMs) know?’. We answered by granting LLMs instrumental knowledge: that is, knowledge gained through using the instrument of next-word generation. We then explored how this type of instrumental knowledge could be related to the more ordinary kind of worldly knowledge exhibited […]

Published on September 20, 2024